Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jose Vazquez

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Critical Care Nurse|August 8, 2022
A Care Step Pathway for the Diagnosis and Treatment of COVID-19-Associated Invasive Fungal Infections in the Intensive Care UnitCarolynn T Jones, R Scott Kopf, Lisa Tushla, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 5, 2005
Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humansLuis Ostrosky-Zeichner, Barbara D Alexander, Daniel H Kett, et al.
Frontiers in Immunology|April 12, 2021
Proteomic Characterization, Biodistribution, and Functional Studies of Immune-Therapeutic Exosomes: Implications for Inflammatory Lung DiseasesMahmoud Elashiry, Ranya Elsayed, Mohamed M Elashiry, et al.
Proceedings of the European Academy of Sciences & Arts|June 7, 2024
FAIR reporting of clinical trials for public health practiceE Andrew Balas, Bussi S Bussi, Noha Asem, et al.
Critical Care (London, England)|November 11, 2024
Length of hospital and intensive care unit stay in patients with invasive candidiasis and/or candidemia treated with rezafungin: a pooled analysis of two randomised controlled trialsPatrick M Honoré, Matteo Bassetti, Oliver A Cornely, et al.
Emerging Infectious Diseases|December 25, 2009
Human listeriosis caused by Listeria ivanoviiChristelle Guillet, Olivier Join-Lambert, Alban Le Monnier, et al.
Archives of Neurology|May 13, 2009
Progressive multifocal leukoencephalopathy and relapsing-remitting multiple sclerosis: a comparative studyAaron Boster, Stephanie Hreha, Joseph R Berger, et al.
Critical Care (London, England)|October 29, 2024
Rezafungin versus caspofungin for patients with candidaemia or invasive candidiasis in the intensive care unit: pooled analyses of the ReSTORE and STRIVE randomised trialsPatrick M Honoré, Massimo Girardis, Marin Kollef, et al.
Lancet (London, England)|November 28, 2022
Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trialGeorge R Thompson, Alex Soriano, Oliver A Cornely, et al.
Respiratory Medicine|January 11, 2026
Impact of home transcutaneous capnography on the assessment of patients with nocturnal hypoxemiaClaudia Mañana Valdés, Ramon Fernandez Alvarez, Laura Abad Chamorro, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Critical Care Nurse|August 8, 2022
A Care Step Pathway for the Diagnosis and Treatment of COVID-19-Associated Invasive Fungal Infections in the Intensive Care UnitCarolynn T Jones, R Scott Kopf, Lisa Tushla, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 5, 2005
Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humansLuis Ostrosky-Zeichner, Barbara D Alexander, Daniel H Kett, et al.
Frontiers in Immunology|April 12, 2021
Proteomic Characterization, Biodistribution, and Functional Studies of Immune-Therapeutic Exosomes: Implications for Inflammatory Lung DiseasesMahmoud Elashiry, Ranya Elsayed, Mohamed M Elashiry, et al.
Proceedings of the European Academy of Sciences & Arts|June 7, 2024
FAIR reporting of clinical trials for public health practiceE Andrew Balas, Bussi S Bussi, Noha Asem, et al.
Critical Care (London, England)|November 11, 2024
Length of hospital and intensive care unit stay in patients with invasive candidiasis and/or candidemia treated with rezafungin: a pooled analysis of two randomised controlled trialsPatrick M Honoré, Matteo Bassetti, Oliver A Cornely, et al.
Emerging Infectious Diseases|December 25, 2009
Human listeriosis caused by Listeria ivanoviiChristelle Guillet, Olivier Join-Lambert, Alban Le Monnier, et al.
Archives of Neurology|May 13, 2009
Progressive multifocal leukoencephalopathy and relapsing-remitting multiple sclerosis: a comparative studyAaron Boster, Stephanie Hreha, Joseph R Berger, et al.
Critical Care (London, England)|October 29, 2024
Rezafungin versus caspofungin for patients with candidaemia or invasive candidiasis in the intensive care unit: pooled analyses of the ReSTORE and STRIVE randomised trialsPatrick M Honoré, Massimo Girardis, Marin Kollef, et al.
Lancet (London, England)|November 28, 2022
Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trialGeorge R Thompson, Alex Soriano, Oliver A Cornely, et al.
Respiratory Medicine|January 11, 2026
Impact of home transcutaneous capnography on the assessment of patients with nocturnal hypoxemiaClaudia Mañana Valdés, Ramon Fernandez Alvarez, Laura Abad Chamorro, et al.
Pageof 6